Arcus Biosciences' cancer drug candidate, quemliclustat, earns FDA orphan drug status, ensuring incentives and exclusivity.

Technology will soon make it possible to develop cheap, widely accessible psychoactive substances that are not harmful in the ...

GSK has claimed its second breakthrough designation from the FDA for antibody-drug conjugate GSK5764227, which it licensed from China's Hansoh Pharma in a $1.7 billion deal. The status has been ...

Temporary Protected Status has long been used as a humanitarian solution for migrants who are unable to return home safely. President Trump’s renewed efforts to scale back such programs have ...

Migraine headaches are severe headaches that may impact your quality of life. Learn which migraine medications are available to treat and prevent migraine pain.

Clarivate has revealed 11 drugs due to launch in 2025 that could top $1 billion in annual sales or be clinical 'game changers' in the next five years.

Learn about uses, side effects, dosage, and more for Izervay, a prescription drug used to treat geographic atrophy due to age-related macular degeneration.